Articles On Virtus Health (ASX:VRT)

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Here’s something for anyone who...

There’s further signs that BGH Capital is digging in for battle at IVF provider Virtus Health. 

As two private equity suitors battle for Australia’s biggest fertility services group Virtus Health, analysts are turning their attention to No.2 player Monash IVF. 

Australian buyout firm BGH Capital is understood to be after a level playing field at Virtus Health.

World Overnight SPI Overnight 6960.00 – 92.00 – 1.30% S&P ASX 200 7139.50 – 36.30 – 0.51% S&P500 4410.13 + 12.19 0.28% Nasdaq Comp 13855.13 + 86.21 0.63% DJIA 34364.50 + 99.13 0.29% S&P500 VIX 29.90 + 1.05 3.64%...

World Overnight SPI Overnight 7006.00 – 49.00 – 0.69% S&P ASX 200 7175.80 – 166.60 – 2.27% S&P500 4397.94 – 84.79 – 1.89% Nasdaq Comp 13768.92 – 385.10 – 2.72% DJIA 34265.37 – 450.02 – 1.30% S&P500 VIX 28.85 + 3.26...

ShareCafeThe Week that Was – January 17-21, 2022 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do so...

ASX health stocks (XHJ index) are down .99% today but faring better than the ASX 200 which has fallen sharply at 1.5%. The HeraMED (ASX:HMD) share price rallied 6.9% to 31 cents in early morning trade before settling ~3.45% as the company a...

21 Jan 2022 - A snapshot of the stocks on the move featuring Whitehaven Coal (ASX:WHC), Nuix (ASX:NXL), & Virtus Health (ASX:VRT).

21 Jan 2022 - Virtus Health (ASX:VRT) welcomes yesterday’s announcement from the Victorian Government after listening to the many people impacted by the suspension of IVF procedure…

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

Bearish sentiment is still gripping the local markets, but the ASX managed to pull into itself into positive territory in the last 30 minutes of trading. The benchmark would have slumped more today had it been not for the Mining sector, whi...

Key points The Virtus Health share price is up 8% after exiting a same-day trading halt The fertility company has received an offer from CapVest to acquire 100% of the business Virtus has granted the investment firm “exclusive due dilige...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up slightly to 7,339.1 points. Four ASX shares that are climbing more than most today are listed b...

Assisted reproductive services multinational Virtus Health (ASX: VRT) has found itself in a love triangle today as UK-based CapVest Partners enters the fray with a $649 million takeover bid, upping the ante by 7 per cent on BGH Capital's at...

ShareCafeBidding War Begins for Virtus Health A London-based private equity firm has overbid local PE group BGH Capital in a new buyout offer for IVF group Virtus Health. CapVest, a new name in PE funds, has indicated an offer of $7.60 a sh...

A London-based private equity firm has made a $7.60 a share indicative bid for Australia’s Virtus Health, valuing its equity at $650 million. 

A rare move by a rare private equity player has set the scene for the year’s first meaty Australian takeover tussle. 

The Virtus Health Ltd (ASX: VRT) share price is in focus as elective surgeries are suspended due to the current Omicron COVID-19 wave. Virtus is an assisted reproductive services provider. It operates in Australia, Denmark, Singapore and th...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week There’s so...

Virtus Health (VRT) suspends all non-urgent elective surgeries in NSW and Victoria as the State Governments cope with the current COVID-19 outbreak In NSW, all non-urgent elective surgeries have been suspended from January 10 but this does...

Highlights The benchmark ASX 200 index was trading 0.52% or 38.8 points down to 7,432 in the first 15-minute trade on Friday. Nervous global stock markets struggled to sustain on Thursday, while the US bond yields steadied. The market...

14 Jan 2022 - Due to the NSW Government suspending all non-elective surgery from January 10, Virtus Health (ASX:VRT) are unable to quantify the financial impact.

14 Jan 2022 - A snapshot of the stocks on the move featuring City Chic (ASX:CCX), Michael Hill (ASX:MHJ), Virtus Health (ASX:VRT).

With many brokers taking a well-earned break over the holiday period, new broker notes are extremely limited. In light of this, listed below are a few recent broker recommendations that are still very relevant today. Here’s are three ASX s...

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

While dealing with a suitor of their own and faced with the prospect of a lengthy court battle with the competition watchdog, the board of in-vitro fertilisation group Virtus Health (ASX: VRT) has determined a takeover of Adora Fertility is...

The ASX 200 Health Index (XHJ) is trading flat at the time of writing, compared to the broader index which is up by 0.47%. In an announcement this week, Australian medicines regulator the TGA ruled that psychedelic drugs cannot be used to t...

The S&P/ASX 200 (ASX: XJO) couldn’t overcome selling pressure from the ASX consumer staples sector, which finished down 4%, as the market fell by less than a point on Tuesday. Real estate and communications outperformed, up 1.1% and 0.7...

MoneyTalks is Stockhead’s regular recap of the stocks, sectors and trends that ASX fund managers and analysts are looking at right now and into 2022. Today we hear from Julian Guido from Perennial Partners‘ Value Smaller Companies Trust whe...

ShareCafeCSL Finally Confirms $A16 Billion Vifor Deal CSL has struck a deal to buy Swiss-based Vifor Pharma Ltd for $A16.4 billion, its biggest deal since listing in 1994. CSL’s announcement on Tuesday evening came after the company asked f...

Resources stocks Quantum Graphite (ASX:QGL) and Altura Mining (ASX:AJM) were reinstated after being suspended for several months and had contrasting fates. Quantum Graphite, which has the ‘Uley’ graphite prokect in South Australia, more tha...

A resilient share market marked time in the face of weak leads, rising Covid case numbers in NSW and a profit warning from Woolworths. The S&P/ASX 200 closed nine-tenths of a point or 0.01 per cent lower after earlier sliding 38 poin...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to get into positive territory but is falling just a touch short. At the time of writing, the benchmark index is down slightly to 7,379.2 points. Four ASX shares tha...

Highlights The ASX 200 traded 0.15% lower by mid-session on Tuesday. Six of 11 sectors traded lower, led by consumer staples. Mesoblast, Woolworths, Afterpay, Coles Group, and Whitehaven Coal topped the ASX losers’ chart. Australi...

Weak US leads and a cost blowout at Woolworths helped drive the share market lower. The S&P/ASX 200 dropped 20 points or 0.27 per cent towards its third loss in four sessions. Gains in defensive and mining stocks were outweighed b...

The ASX 200 Health Index (XHJ) is trading higher by 0.27% at the time of writing, compared to the broader index which is down by 0.40%. Fertility company Virtus Health (ASX:VRT) is being pursued by a takeover offer from BGH Capital. BGH, wh...

The Virtus Health Ltd (ASX: VRT) share price is soaring. It’s up 30% after the fertility, diagnostic and day hospital business announced it had received a takeover bid. Virtus Health share price jumps on takeover approach The fertility com...

Assisted reproductive services company Virtus Health (ASX: VRT) has received a non-binding takeover offer from private equity firm BGH Capital valuing the target at approximately $607 million, representing a 36 per cent premium to yesterday...

The IVF provider was scrambling to come up with some sort of M&A defence on Monday night, with a private equity suitor breathing down its neck.

UBS’s equities desk was seeking to buy up to a 19.9 per cent stake in Virtus Health on Monday night ahead of a potential $600 million bid for the company.

Aussie shares were poised to open little changed after rate-hike worries and retail margin pressures weighed on Wall Street. ASX futures inched up two points or 0.03 per cent, signalling a subdued start following two straight declines. T...

Australian shares looked set to start a new week little changed as a recovery in the dollar and declines in key commodities offset gains on Wall Street. ASX futures eased three points or 0.04 per cent, signalling a flat start following F...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week The AGM sea...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week With a slew o...

Australia’s Federal Court has granted the ACCC an interlocutory injunction to temporarily stop Virtus Health (VRT) from acquiring a string of fertility clinics The two companies had previously said they would go ahead with the transaction...

The ACCC highlights mergers and acquisitions, big tech power and court requirements as some of the biggest challenges faced by Australian economic competition Chair Rod Sims says the competition watchog will seek more control over mergers...

Cronos Australia (ASX:CAU) jumped 7% this morning, after reporting significant growth in the sales of its Adaya medicinal cannabis range — up 90% from the previous quarter. Sales of Adaya for the first quarter have exceeded $1.1m, Cronos sa...

The share market continued to put the September blues behind it, rising to its highest level of the month after employment data showed the hit from lockdowns may be lighter than economists anticipated. The S&P/ASX 200 finished 39 poi...

The share market recouped three days of losses after September employment data met expectations and Wall Street shrugged off a flurry of risk events. The S&P/ASX 200 climbed 55 points or 0.76 per cent to its highest level of the mont...